dr. zakashansky on solo2 with maintenance olaparib in relapsed brca1/2 ovarian cancer
Published 4 years ago • 194 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
2:00
dr. zakashansky on the benefit of maintenance olaparib in brca ovarian cancer
-
1:09
dr. zakashansky on repeat exposure to parp inhibitors in patients with ovarian cancer
-
25:59
final overall survival results from the phase 3 solo2 trial for ovarian cancer
-
2:23
dr. poveda on the results of the solo2 trial in ovarian cancer
-
1:57
7-year os from solo1: sustained benefit with maintenance olaparib
-
4:09
case 2: maintenance in brca1/2wt, hr-proficient ovarian cancer
-
3:13
dr. herzog on the fda approval of olaparib/bevacizumab as frontline maintenance in ovarian cancer
-
1:38
dr. liu on cediranib/olaparib in recurrent ovarian cancer
-
3:24
solo-1: olaparib or placebo for patients with newly diagnosed brca-mutated advanced ovarian cancer
-
4:54
impact of solo-1 on advanced ovarian cancer management
-
7:38
results from phiii solo1 trial in brcam ovarian cancer
-
1:00:35
dr susana banerjee on current treatments and the latest advances in ovarian cancer
-
0:57
new treatment for ovarian cancer | emery salom, md
-
1:48:38
ovarian cancer: what you need to know
-
9:22
treating brca ovarian cancer
-
59:00
the era of individualised treatment in ovarian cancer, with professor sean kehoe
-
3:56
solo1 trial of maintenance olaparib in advanced ovarian cancer | susana banerjee
-
1:44
ctdna measurement via liquid biopsies in cancer of unknown primary